Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma
2023 · Pharmacological Research · 41 citations
https://doi.org/10.1016/j.phrs.2023.106701
Q
Qi Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.3K
Citations
16
h-index
18
i10-index
Qi Zhang is an academic researcher from Zhongda Hospital Southeast University. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Virus-based gene therapy research. The author has an h-index of 16, co-authored 38 publications.
ORCID: 0000-0003-3813-8032Papers by this author
worksOncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
2021 · Molecular Therapy — Oncolytics · 37 citations
https://doi.org/10.1016/j.omto.2021.11.018
Runx3-overexpression cooperates with ex vivo AKT inhibition to generate receptor-engineered T cells with better persistence, tumor-residency, and antitumor ability
2023 · Journal for ImmunoTherapy of Cancer · 25 citations
https://doi.org/10.1136/jitc-2022-006119
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors
2023 · Cell Death Discovery · 25 citations
https://doi.org/10.1038/s41420-023-01626-4
Enhanced platelet function through CAR-T cell therapy in relapsed/refractory multiple myeloma
2024 · Clinical and Experimental Medicine · 1 citations
https://doi.org/10.1007/s10238-024-01477-y
Additional file 9: of Rice nucleosome patterns undergo remodeling coincident with stress-induced gene expression
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5830005
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat